Invention Grant
- Patent Title: Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
-
Application No.: US15584459Application Date: 2017-05-02
-
Publication No.: US10172840B2Publication Date: 2019-01-08
- Inventor: Otis Clinton Attucks
- Applicant: vTv Therapeutics LLC
- Applicant Address: US CA High Point
- Assignee: vTv Therapeutics LLC
- Current Assignee: vTv Therapeutics LLC
- Current Assignee Address: US CA High Point
- Agent Samuel B. Rollins
- Main IPC: C07D235/04
- IPC: C07D235/04 ; A61K31/437 ; A61K31/428 ; A61K31/56
Abstract:
The disclosure provides pharmaceutical compositions comprising Bach1 Inhibitors and Nrf2 Activators. The disclosure also provides methods of treating diseases such as psoriasis, multiple sclerosis, and COPD comprising administering a Bach1 Inhibitor and a Nrf2 Activator to a subject in need thereof.
Public/Granted literature
- US20170231967A1 Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof Public/Granted day:2017-08-17
Information query
